Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress

SIMPLE SUMMARY: NRP-1, a co-receptor of the EGFR, represented an interesting candidate to investigate in HNSCC, as Cetuximab, in combination with radio and chemotherapy, provided the first targeted therapy scheme approved by the FDA as a standard of care for patients with recurrent or metastatic HNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Napolitano, Virginia, Russo, Daniela, Morra, Francesco, Merolla, Francesco, Varricchio, Silvia, Ilardi, Gennaro, Di Crescenzo, Rosa Maria, Martino, Francesco, Mascolo, Massimo, Celetti, Angela, Tamagnone, Luca, Staibano, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345038/
https://www.ncbi.nlm.nih.gov/pubmed/34359721
http://dx.doi.org/10.3390/cancers13153822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345038/
https://www.ncbi.nlm.nih.gov/pubmed/34359721
http://dx.doi.org/10.3390/cancers13153822

Ejemplares similares